|
Volumn 60, Issue 3, 2007, Pages 457-458
|
Therapy for whipple's disease
|
Author keywords
Atimicrobial therapy; Sulphonamides; Trimethoprim; Tropheryma whipplei
|
Indexed keywords
CEFTRIAXONE;
COTRIMOXAZOLE;
DIHYDROFOLATE REDUCTASE;
DIHYDROPTEROATE SYNTHASE;
DOXYCYCLINE;
HYDROXYCHLOROQUINE;
MEROPENEM;
PENICILLIN G;
PYRIMETHAMINE;
STREPTOMYCIN;
SULFADIAZINE;
SULFAMETHOXAZOLE;
SULFONAMIDE;
TETRACYCLINE DERIVATIVE;
TRIMETHOPRIM;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL THERAPY;
ARTICLE;
BACTERIAL ENDOCARDITIS;
BLOOD BRAIN BARRIER;
CLINICAL TRIAL;
DRUG ACCUMULATION;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG PENETRATION;
DRUG POTENTIATION;
DRUG SELECTIVITY;
ENZYME INHIBITION;
EVIDENCE BASED MEDICINE;
GENE MUTATION;
GENOME ANALYSIS;
HUMAN;
INTESTINE LIPODYSTROPHY;
MAINTENANCE THERAPY;
MONOTHERAPY;
NEUROLOGIC DISEASE;
NONHUMAN;
PRACTICE GUIDELINE;
PROGNOSIS;
Q FEVER;
TREATMENT DURATION;
TROPHERYMA WHIPPELII;
ANTI-BACTERIAL AGENTS;
HUMANS;
NERVOUS SYSTEM DISEASES;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
WHIPPLE DISEASE;
|
EID: 34548136212
PISSN: 03057453
EISSN: 14602091
Source Type: Journal
DOI: 10.1093/jac/dkm259 Document Type: Article |
Times cited : (24)
|
References (10)
|